Craig A. Collard - 19 Jan 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Collard
Issuer symbol
HRTX
Transactions as of
19 Jan 2024
Net transactions value
$0
Form type
4
Filing time
19 Jan 2024, 20:58:25 UTC
Previous filing
17 Nov 2023
Next filing
05 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +1,324,502 $0.000000 1,324,502 19 Jan 2024 Common Stock 1,324,502 $2.09 Direct F1
transaction HRTX Restricted Stock Units Award $0 +220,750 $0.000000 220,750 19 Jan 2024 Common Stock 220,750 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024).
F2 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).